Submission Details
| 510(k) Number | K172656 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 05, 2017 |
| Decision Date | May 01, 2018 |
| Days to Decision | 238 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K172656 is an FDA 510(k) clearance for the BiliLux, a Unit, Neonatal Phototherapy (Class II — Special Controls, product code LBI), submitted by Draeger Medical Systems, Inc. (Telford, US). The FDA issued a Cleared decision on May 1, 2018, 238 days after receiving the submission on September 5, 2017. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5700.
| 510(k) Number | K172656 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 05, 2017 |
| Decision Date | May 01, 2018 |
| Days to Decision | 238 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | LBI — Unit, Neonatal Phototherapy |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5700 |